These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14684293)

  • 21. Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI).
    Miller WH; Seefeld MA; Newlander KA; Uzinskas IN; Burgess WJ; Heerding DA; Yuan CC; Head MS; Payne DJ; Rittenhouse SF; Moore TD; Pearson SC; Berry V; DeWolf WE; Keller PM; Polizzi BJ; Qiu X; Janson CA; Huffman WF
    J Med Chem; 2002 Jul; 45(15):3246-56. PubMed ID: 12109908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A strategy to discover inhibitors of Bacillus subtilis surfactin-type phosphopantetheinyl transferase.
    Yasgar A; Foley TL; Jadhav A; Inglese J; Burkart MD; Simeonov A
    Mol Biosyst; 2010 Feb; 6(2):365-75. PubMed ID: 20094656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, biological screening and molecular modeling studies of novel 3-chloro-4-substituted-1-(2-(1H-benzimidazol-2-yl)phenyl))-azetidin-2-ones.
    Chhajed SS; Upasani CD
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):504-8. PubMed ID: 21823835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents.
    Seefeld MA; Miller WH; Newlander KA; Burgess WJ; Payne DJ; Rittenhouse SF; Moore TD; DeWolf WE; Keller PM; Qiu X; Janson CA; Vaidya K; Fosberry AP; Smyth MG; Jaworski DD; Slater-Radosti C; Huffman WF
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2241-4. PubMed ID: 11527706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A distal methyl substituent attenuates mitochondrial protein synthesis inhibition in oxazolidinone antibacterials.
    Renslo AR; Atuegbu A; Herradura P; Jaishankar P; Ji M; Leach KL; Huband MD; Dermyer MR; Wu L; Vara Prasad JV; Gordeev MF
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5036-40. PubMed ID: 17681758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 6-Anilinouracil-based inhibitors of Bacillus subtilis DNA polymerase III: antipolymerase and antimicrobial structure-activity relationships based on substitution at uracil N3.
    Tarantino PM; Zhi C; Gambino JJ; Wright GE; Brown NC
    J Med Chem; 1999 Jun; 42(11):2035-40. PubMed ID: 10354411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial activity of indole alkaloids from Aspidosperma ramiflorum.
    Tanaka JC; Silva CC; Oliveira AJ; Nakamura CV; Dias Filho BP
    Braz J Med Biol Res; 2006 Mar; 39(3):387-91. PubMed ID: 16501818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-Benzylidenethiazolidin-4-ones as multitarget inhibitors of bacterial Mur ligases.
    Tomasić T; Zidar N; Kovac A; Turk S; Simcic M; Blanot D; Müller-Premru M; Filipic M; Grdadolnik SG; Zega A; Anderluh M; Gobec S; Kikelj D; Peterlin Masic L
    ChemMedChem; 2010 Feb; 5(2):286-95. PubMed ID: 20024979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.
    Levin JI; Chen JM; Du MT; Nelson FC; Killar LM; Skala S; Sung A; Jin G; Cowling R; Barone D; March CJ; Mohler KM; Black RA; Skotnicki JS
    Bioorg Med Chem Lett; 2002 Apr; 12(8):1199-202. PubMed ID: 11934588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 1: Structure-based design of novel acetylenic P1' groups.
    Chen JM; Jin G; Sung A; Levin JI
    Bioorg Med Chem Lett; 2002 Apr; 12(8):1195-8. PubMed ID: 11934587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acyl carrier protein synthases from gram-negative, gram-positive, and atypical bacterial species: Biochemical and structural properties and physiological implications.
    McAllister KA; Peery RB; Zhao G
    J Bacteriol; 2006 Jul; 188(13):4737-48. PubMed ID: 16788183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli.
    Brandish PE; Kimura KI; Inukai M; Southgate R; Lonsdale JT; Bugg TD
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1640-4. PubMed ID: 8807054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Wang XL; Zhang YB; Tang JF; Yang YS; Chen RQ; Zhang F; Zhu HL
    Eur J Med Chem; 2012 Nov; 57():373-82. PubMed ID: 23124163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.
    Macielag MJ; Demers JP; Fraga-Spano SA; Hlasta DJ; Johnson SG; Kanojia RM; Russell RK; Sui Z; Weidner-Wells MA; Werblood H; Foleno BD; Goldschmidt RM; Loeloff MJ; Webb GC; Barrett JF
    J Med Chem; 1998 Jul; 41(16):2939-45. PubMed ID: 9685233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A series of heterocyclic inhibitors of phenylalanyl-tRNA synthetases with antibacterial activity.
    Yu XY; Finn J; Hill JM; Wang ZG; Keith D; Silverman J; Oliver N
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1343-6. PubMed ID: 14980695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and antibacterial activities of thiouracil derivatives containing acyl thiourea as SecA inhibitors.
    Cui P; Li X; Zhu M; Wang B; Liu J; Chen H
    Bioorg Med Chem Lett; 2017 May; 27(10):2234-2237. PubMed ID: 28041832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
    Zhang F; Wen Q; Wang SF; Shahla Karim B; Yang YS; Liu JJ; Zhang WM; Zhu HL
    Bioorg Med Chem Lett; 2014 Jan; 24(1):90-5. PubMed ID: 24332628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel 3-substituted ocotillol-type triterpenoid derivatives as antibacterial candidates.
    Bi Y; Ma C; Zhang H; Zhou Z; Yang J; Zhang Z; Meng Q; Lewis PJ; Xu J
    Chem Biol Drug Des; 2014 Oct; 84(4):489-96. PubMed ID: 24811479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and characterization of inhibitors of the essential histidine kinase, YycG in Bacillus subtilis and Staphylococcus aureus.
    Watanabe T; Hashimoto Y; Yamamoto K; Hirao K; Ishihama A; Hino M; Utsumi R
    J Antibiot (Tokyo); 2003 Dec; 56(12):1045-52. PubMed ID: 15015732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of novel antibacterial agents with inhibitory activity against DNA polymerase III.
    Ali A; Aster SD; Graham DW; Patel GF; Taylor GE; Tolman RL; Painter RE; Silver LL; Young K; Ellsworth K; Geissler W; Harris GS
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2185-8. PubMed ID: 11514166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.